About: CCR1 blockade reduces interstitial inflammation and fibrosis in mice with glomerulosclerosis and nephrotic syndrome     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : http://linked.opendata.cz/ontology/domain/vavai/Vysledek, within Data Space : linked.opendata.cz associated with source document(s)

AttributesValues
rdf:type
Description
  • Autoři zkoumali vliv blokátoru CCR1 chemokinového receptoru BX471 u myššího modelu adriamycinem indukované fokálně segmentální glomerulosklerózy, onemocnění charakterizovaného nefrotickým syndromem a progredující fibrózou intersticia ledviny. BX471 výrazně redukuje počet makrofágů a T lymfocytů v intersticiu adriamycinem poškozených ledvin. Počet intersticiálních fibroblastů a objem intersticia ledviny byly léčbou BX471 sníženy oproti neléčenému divokému kmeni, naopak na rozvoj glomerulosklerózy a proteinurie neměla léčba vliv. Blokáda CCR1 může být novou terapeutickou strategií u progresivních nefropatií, jako je FSGS. (cs)
  • Background. CC chemokines mediate leukocyte infiltration into inflamed tissue. We have recently shown that blockade of the CC chemokine receptor CCR1 reduces interstitial inflammation and fibrosis in murine obstructive nephropathy. However, it is not known whether CCR 1 blockade is protective in progressive renal injury associated with severe proteinuria. We therefore studied the effect of the small-molecule CCR1 antagonist BX471 in a murine model of adriamycin-induced focal segmental glomerulosclerosis (FSGS) with nephrotic syndrome and progressive interstitial inflammation and fibrosis. Methods. Adriamycin nephropathy with persistent proteinuria was induced in male BALB/c mice by two intravenous injections of adriamycin (13 mg/kg) at day 0 and 14. BX471 treatment was started at day 14 when proteinuria and interstitial inflammation had developed. At 6 weeks, renal histology was studied by morphometry and immunohistochemistry. Results. At week 6, adriamycin-treated mice showed FSGS, associated with tu
  • Background. CC chemokines mediate leukocyte infiltration into inflamed tissue. We have recently shown that blockade of the CC chemokine receptor CCR1 reduces interstitial inflammation and fibrosis in murine obstructive nephropathy. However, it is not known whether CCR 1 blockade is protective in progressive renal injury associated with severe proteinuria. We therefore studied the effect of the small-molecule CCR1 antagonist BX471 in a murine model of adriamycin-induced focal segmental glomerulosclerosis (FSGS) with nephrotic syndrome and progressive interstitial inflammation and fibrosis. Methods. Adriamycin nephropathy with persistent proteinuria was induced in male BALB/c mice by two intravenous injections of adriamycin (13 mg/kg) at day 0 and 14. BX471 treatment was started at day 14 when proteinuria and interstitial inflammation had developed. At 6 weeks, renal histology was studied by morphometry and immunohistochemistry. Results. At week 6, adriamycin-treated mice showed FSGS, associated with tu (en)
Title
  • CCR1 blockade reduces interstitial inflammation and fibrosis in mice with glomerulosclerosis and nephrotic syndrome
  • CCR1 blockade reduces interstitial inflammation and fibrosis in mice with glomerulosclerosis and nephrotic syndrome (en)
  • Blokáda CCR1 snižuje zánětlivou infiltraci a fibrózu intersticia u myší s glomerulosklerózou a nefrotickým syndromem (cs)
skos:prefLabel
  • CCR1 blockade reduces interstitial inflammation and fibrosis in mice with glomerulosclerosis and nephrotic syndrome
  • CCR1 blockade reduces interstitial inflammation and fibrosis in mice with glomerulosclerosis and nephrotic syndrome (en)
  • Blokáda CCR1 snižuje zánětlivou infiltraci a fibrózu intersticia u myší s glomerulosklerózou a nefrotickým syndromem (cs)
skos:notation
  • RIV/00216208:11120/04:00000975!RIV09-MSM-11120___
http://linked.open...avai/riv/aktivita
http://linked.open...avai/riv/aktivity
  • S
http://linked.open...iv/cisloPeriodika
  • 6
http://linked.open...vai/riv/dodaniDat
http://linked.open...aciTvurceVysledku
http://linked.open.../riv/druhVysledku
http://linked.open...iv/duvernostUdaju
http://linked.open...titaPredkladatele
http://linked.open...dnocenehoVysledku
  • 556948
http://linked.open...ai/riv/idVysledku
  • RIV/00216208:11120/04:00000975
http://linked.open...riv/jazykVysledku
http://linked.open.../riv/klicovaSlova
  • chemokines; receptor blockade; focal segmental glomerulosclerosis; progressive nephropathy; fibrosis; macrophages (en)
http://linked.open.../riv/klicoveSlovo
http://linked.open...odStatuVydavatele
  • US - Spojené státy americké
http://linked.open...ontrolniKodProRIV
  • [34A6A1E8565B]
http://linked.open...i/riv/nazevZdroje
  • Kidney International
http://linked.open...in/vavai/riv/obor
http://linked.open...ichTvurcuVysledku
http://linked.open...cetTvurcuVysledku
http://linked.open...UplatneniVysledku
http://linked.open...v/svazekPeriodika
  • 66
http://linked.open...iv/tvurceVysledku
  • Eis, Václav
  • Anders, H. J.
  • Schlondorff, D.
  • Vielhauer, V.
  • Grone, H. J.
  • Kretzler, M.
  • Strutz, F.
  • Berning, E.
  • Horuk, R.
  • Segerer, S.
http://linked.open...ain/vavai/riv/wos
  • 000225026200016
issn
  • 0085-2538
number of pages
http://localhost/t...ganizacniJednotka
  • 11120
Faceted Search & Find service v1.16.118 as of Jun 21 2024


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 07.20.3240 as of Jun 21 2024, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (126 GB total memory, 48 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software